MAM
BMY icon

Melqart Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Melqart Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-241,500
Closed -$11.4M – 32
2019
Q1 		$11.4M Buy
+241,500
New +$12M 1.06% 26

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Melqart Asset Management's BMY Position: Q2 2019 in Review

Melqart Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 241,500 shares — an estimated $11.4M sold.

Melqart Asset Management first reported a position in BMY in Q1 2019 and held it in 1 quarter. The position peaked at $11.4M in Q1 2019. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

  • Melqart Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
  • Melqart Asset Management sold 241,500 Bristol-Myers Squibb shares in Q2 2019, an estimated $11.4M.
  • Melqart Asset Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 1 quarter.
  • Melqart Asset Management's Bristol-Myers Squibb position peaked at $11.4M in Q1 2019.
  • 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Melqart Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.